These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8375244)
1. Hemostasis variables in type I diabetic patients without demonstrable vascular complications. el Khawand C; Jamart J; Donckier J; Chatelain B; Lavenne E; Moriau M; Buysschaert M Diabetes Care; 1993 Aug; 16(8):1137-45. PubMed ID: 8375244 [TBL] [Abstract][Full Text] [Related]
2. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus. Rosove MH; Frank HJ; Harwig SS Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650 [TBL] [Abstract][Full Text] [Related]
4. Platelet function in male diabetics with and without macrovascular complications. Tóth L; Szénási P; Jámbor G; Kammerer L; Romics L Diabetes Res Clin Pract; 1992 Feb; 15(2):143-8. PubMed ID: 1563330 [TBL] [Abstract][Full Text] [Related]
5. [Some parameters of hemostasis and fibrinolysis in diabetic patients]. Telejko B; Zonenberg A; Borejszo I; Kinalska I Pol Arch Med Wewn; 1998 Aug; 100(2):133-8. PubMed ID: 10101928 [TBL] [Abstract][Full Text] [Related]
6. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
7. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes. Jokl R; Klein RL; Lopes-Virella MF; Colwell JA Diabetes Care; 1995 Aug; 18(8):1150-5. PubMed ID: 7587850 [TBL] [Abstract][Full Text] [Related]
9. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications. Gisinger C; Schernthaner G Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622 [TBL] [Abstract][Full Text] [Related]
10. Relationships between metabolic and hemostatic variables in uncomplicated diabetes. Vergani C; Bettale G; Mari D; Mannucci PM Acta Diabetol Lat; 1981; 18(3):199-206. PubMed ID: 6171128 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study. Cho NH; Becker DJ; Ellis D; Kuller LH; Drash AL; Orchard TJ J Diabetes Complications; 1992; 6(1):12-8. PubMed ID: 1562753 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy. Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481 [TBL] [Abstract][Full Text] [Related]
14. [Thrombocyte function in children with Type I diabetes mellitus. Cross-sectional study]. Nowak-Göttl U; Kreuz WD; Besier E; Grüttner HP; Krackhardt B; Breddin HK; Kornhuber B Monatsschr Kinderheilkd; 1991 Dec; 139(12):821-5. PubMed ID: 1770958 [TBL] [Abstract][Full Text] [Related]
15. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH; Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968 [TBL] [Abstract][Full Text] [Related]
17. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Véricel E; Januel C; Carreras M; Moulin P; Lagarde M Diabetes; 2004 Apr; 53(4):1046-51. PubMed ID: 15047620 [TBL] [Abstract][Full Text] [Related]
18. Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients. Hughes A; McVerry BA; Wilkinson L; Goldstone AH; Lewis D; Bloom A Acta Haematol; 1983; 69(4):254-9. PubMed ID: 6219531 [TBL] [Abstract][Full Text] [Related]
19. Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin. Koutts J; Walsh PN; Plow EF; Fenton JW; Bouma BN; Zimmerman TS J Clin Invest; 1978 Dec; 62(6):1255-63. PubMed ID: 311783 [TBL] [Abstract][Full Text] [Related]
20. Relationship between fatty acid pattern and platelet aggregation in long-term insulin-dependent type I diabetics. Schimke E; Hildebrandt R; Grzeskowiak B Biomed Biochim Acta; 1988; 47(10-11):S274-7. PubMed ID: 3248113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]